These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3365236)

  • 1. Conformational analysis of morphiceptin by NMR spectroscopy.
    Castiglione-Morelli MA; Hartrodt B; Neubert K; Temussi PA; Trivellone E
    Biochem Biophys Res Commun; 1988 Apr; 152(2):512-8. PubMed ID: 3365236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
    Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
    Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assignment of the 1H-NMR resonances of the four rotamers of beta-casomorphin-5 in DMSO.
    Delaet NG; Verheyden PM; Tourwé D; Van Binst G
    Biopolymers; 1991 Oct; 31(12):1409-16. PubMed ID: 1816877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A topochemical approach to explain morphiceptin bioactivity.
    Yamazaki T; Ro S; Goodman M; Chung NN; Schiller PW
    J Med Chem; 1993 Mar; 36(6):708-19. PubMed ID: 8384662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and conformational studies of [Val4]morphiceptin and [D-Val4]morphiceptin analogs incorporating cis-2-aminocyclopentane carboxylic acid as a peptidomimetic for proline.
    Yamazaki T; Pröbsti A; Schiller PW; Goodman M
    Int J Pept Protein Res; 1991 May; 37(5):364-81. PubMed ID: 1917292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct conformational preferences of three cyclic beta-casomorphin-5 analogs determined using NMR spectroscopy and theoretical analysis.
    Carpenter KA; Schiller PW; Schmidt R; Wilkes BC
    Int J Pept Protein Res; 1996 Jul; 48(1):102-11. PubMed ID: 8844269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of glycation on cis/trans isomerization and tautomerization in novel morphiceptin-related Amadori compounds.
    Zigrović I; Kidric J; Horvat S
    Glycoconj J; 1998 Jun; 15(6):563-70. PubMed ID: 9881761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational characteristics of receptor-selective opioid peptides. 1H n.m.r. and c.d. spectroscopic studies of delta-kephalin and [Val4]morphiceptin.
    Doi M; Tanaka M; Ikuma K; Nabae M; Kitamura K; Inoue M; Ishida T
    Biochem J; 1988 Apr; 251(2):581-8. PubMed ID: 2840898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a specific mu-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins.
    Chang KJ; Su YF; Brent DA; Chang JK
    J Biol Chem; 1985 Aug; 260(17):9706-12. PubMed ID: 2991261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal ion effects on the cis/trans isomerization equilibrium of proline in short-chain peptides: a solution NMR study.
    Gaggelli E; D'Amelio N; Gaggelli N; Valensin G
    Chembiochem; 2001 Aug; 2(7-8):524-9. PubMed ID: 11828485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topochemical analysis of morphiceptin and dermorphin bioactivities.
    Yamazaki T; Ro S; Goodman M
    Biochem Biophys Res Commun; 1991 Dec; 181(2):664-70. PubMed ID: 1661586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid activities of morphiceptin-like peptides latent in various natural proteins.
    Shimohigashi Y; Sakaguchi K; Sakamoto H; Waki M; Costa T
    Pept Res; 1990; 3(5):216-23. PubMed ID: 1966866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphiceptin analogues containing a dipeptide mimetic structure: an investigation on the bioactive topology at the mu-receptor.
    Grieco P; Giusti L; Carotenuto A; Campiglia P; Calderone V; Lama T; Gomez-Monterrey I; Tartaro G; Mazzoni MR; Novellino E
    J Med Chem; 2005 May; 48(9):3153-63. PubMed ID: 15857121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues.
    Tancredi T; Temussi PA; Picone D; Amodeo P; Tomatis R; Salvadori S; Marastoni M; Santagada V; Balboni G
    Biopolymers; 1991 May; 31(6):751-60. PubMed ID: 1932571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu opioid receptors participate in the excitatory effect of opiates in the hippocampal slice.
    Bostock E; Dingledine R; Xu G; Chang KJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):512-7. PubMed ID: 6094789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
    Chang KJ; Wei ET; Killian A; Chang JK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):403-8. PubMed ID: 6313901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H- and 13C-NMR investigations on cis-trans isomerization of proline peptide bonds and conformation of aromatic side chains in H-Trp-(Pro)n-Tyr-OH peptides.
    Poznański J; Ejchart A; Wierzchowski KL; Ciurak M
    Biopolymers; 1993 May; 33(5):781-95. PubMed ID: 8393714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural function of C-terminal amidation of endomorphin. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid, studied by 1H-NMR spectroscopy, molecular calculation, and X-ray crystallography.
    In Y; Minoura K; Tomoo K; Sasaki Y; Lazarus LH; Okada Y; Ishida T
    FEBS J; 2005 Oct; 272(19):5079-97. PubMed ID: 16176278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies.
    Mirowski M; Wiercioch R; Janecka A; Balcerczak E; Byszewska E; Birnbaum G; Byzia S; Garnuszek P; Wierzbicki R
    Nucl Med Biol; 2004 May; 31(4):451-7. PubMed ID: 15093815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.